Симптоматические инфекции мочевыводящих путей у беременных и небеременных пациенток. Что общего и в чем различия?


DOI: https://dx.doi.org/10.18565/urology.2024.6.157-164

Локшин К.Л.

ООО «Джи Эм Эс Хоспитал», Москва, Россия
Данный обзор посвящен особенностям диагностики и лечения симптомных инфекций мочевыводящих путей у беременных и небеременных женщин.
С использованием данных современных исследований и самых актуальных клинических рекомендаций проведен анализ изменений резистентности возбудителей инфекций мочевыводящих путей при циститах и пиелонефритах у женщин.
Рассмотрены актуальные принципы подбора и правила проведения антибиотикотерапии у беременных и небеременных пациенток при симптомных инфекциях мочевыводящих путей.

Литература


1. Schmiemann G, Kniehl E, Gebhardt K, et al. The diagnosis of urinary tract infection: a systematic review. Dtsch Arztebl Int 2010;107:361–367.


2. Chu CM, Lowder JL. Diagnosis and treatment of urinary tract infections across age groups. Am J Obstet Gynecol. 2018;219:40–51.


3. Alós JI. Epidemiología y etiología de la infección urinaria comunitaria. Sensibilidad antimicrobiana de los principales patógenos y significado clínico de la resistencia. Enferm Infecc Microbiol Clin. 2005;23:3–8.


4. Guidelines for Perinatal Care. AAP, Elk Grove Village, IL; ACOG, Washington DC: American Academy of Pediatrics, American College of Obstetricians and Gynecologists; 2017. 8th ed:


5. Yefet E, Bejerano A, Iskander R, Zilberman Kimhi T, Nachum Z. The Association between Gestational Diabetes Mellitus and Infections in Pregnancy-Systematic Review and Meta-Analysis. Microorganisms. 2023;11(8):1956.


6. Mazor-Dray E, Levy A, Schlaeffer F, Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?. J Matern Fetal Neonatal Med. 2009(2):124–28.


7. Yan L, Jin Y, Hang H, Yan B. The association between urinary tract infection during pregnancy and preeclampsia: A meta-analysis. Medicine (Baltimore). 2018(36):e12192.


8. Gilstrap LC, Ramin SM. Urinary tract infections during pregnancy. Obstetrics and Gynecology Clinics of North America. 2001;28(3):581–591.


9. Rodriguez PN, Klein AS: Management of urolithiasis in pregnancy. Surg Gynecol Obstet. 1988;166:103–106.


10. Hill, J.B., et al. Acute pyelonephritis in pregnancy. Obstet Gynecol. 2005;105:18.


11. Bader, M.S., et al. An update on the management of urinary tract infections in the era of antimicrobial resistance. Postgrad Med, 2017. 129: 242.


12. Geerlings S.E. et al. SWAB Guidelines for Antimicrobial Therapy of Complicated Urinary Tract Infections in Adults. SWAB Guidelines, 2013.


13. Hooton T.M. et al. Diagnosis, prevention, and treatment of catheter-associated urinary tract infection in adults: 2009 International Clinical Practice Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010;50:625.


14. Peterson J., et al. Identification and pretherapy susceptibility of pathogens in patients with complicated urinary tract infection or acute pyelonephritis enrolled in a clinical study in the United States from November 2004 through April 2006. Clin Ther. 2007;29:2215.


15. Rodríguez-Baño J, Picón E, Gijón P, Hernández JR, Ruíz M, Peña C, Almela M, Almirante B, Grill F, Colomina J, Giménez M, Oliver A, Horcajada JP, Navarro G, Coloma A, Pascual A; Spanish Network for Research in Infectious Diseases (REIPI). Community-onset bacteremia due to extended-spectrum beta-lactamase-producing Escherichia coli: risk factors and prognosis. Clin Infect Dis. 2010;50(1):40–48.


16. European Association of Urology Guidelines on Urological Infections, 2024 Edition. https://d56bochluxqnz.cloudfront.net/documents/full-guideline. EAU-Guidelines-on-Urological-Infections-2024.pdf.


17. Clinical recommendations «Urinary tract infection during pregnancy» of the Ministry of Health of the Russian Federation, 2022, https://cr.minzdrav.gov.ru/recomend/719_1. Russian (Клинические рекомендации «Инфекция мочевых путей при беременности» МЗ РФ, 2022 г., https://cr.minzdrav.gov.ru/recomend/719_1).


18. Clinical recommendations «Cystitis in women» of the Ministry of Health of the Russian Federation, 2024, https://cr.minzdrav.gov.ru/recomend/14_3. Russian (Клинические рекомендации «Цистит у женщин» МЗ РФ, 2024 г., https://cr.minzdrav.gov.ru/recomend/14_3).


19. Palagin I.S. et al. Antibiotic resistance of pathogens of community-acquired urinary tract infections in Russia: results of the multicenter study «DARMIS-2018». Clinical microbiology and antimicrobial chemotherapy. 2019;21(2):134–146. Russian (Палагин И.С. и соавт. Антибиотикорезистентность возбудителей внебольничных инфекций мочевых путей в России: результаты многоцентрового исследования «ДАРМИС-2018». Клиническая микробиология и антимикробная химиотерапия. 2019;21(2):134–146).


20. The AMRCloud platform. Dataset: DARMIS 2009-2011, 2017-2018 Interpretation (IPC/DD): EUCAST v11.0 (2021). https://app.amrcloud.net/rus/?id=darmis&public=T. Russian (Платформа AMRCloud. Набор данных: ДАРМИС 2009-2011, 2017-2018 Интерпретация (МПК/DD): EUCAST v11.0 (2021). https://app.amrcloud.net/rus/?id=darmis&public=T).


21. Kresken M. et al. Comparative in vitro activity of oral antimicrobial agents against Enterobacteriaceae from patients with community-acquired urinary tract infections in three European countries. Clin Microbiol Infect 2016;22:63.e1–63.e5


22. Bader MS, Loeb M, Leto D, Brooks AA. Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents. Postgrad Med. 2020;132(3):234–250. doi: 10.1080/00325481.2019.1680052.


23. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun. 2001;69(7):4572–79. doi: 10.1128/IAI.69.7.4572-4579.2001.


24. Dhakal BK, Kulesus RR, Mulvey MA. Mechanisms and consequences of bladder cell invasion by uropathogenic Escherichia coli. Eur J Clin Invest. 2008;38 Suppl 2:2–11. doi: 10.1111/j.1365-2362.2008.01986.x.


25. Lokshin K.L., Gevorkyan A.R., Evdokimov M.E. and others. Analysis of the effectiveness of standard antibiotic therapy and the risk of recurrence of acute uncomplicated cystitis in women of childbearing age. An open randomized comparative study. Consilium medicum. 2012;14(4):51–56. Russian (Локшин К.Л., Геворкян А.Р., Евдокимов М.Е. и др. Анализ эффективности стандартной антибиотикотерапии и риска рецидивирования острых неосложненных циститов у женщин детородного возраста. Открытое рандомизированное сравнительное исследование. Consilium medicum. 2012;14(4):51–56).


26. Cunningham F., Leveno K., Bloom S., Hauth J., Gilstrap L., Wenstrom K. Renal and urinary disorders. in Williams Obstetric, Chapter 48, pp. 1093–1110, McGraw-Hill, New York, NY, USA, 22nd edition, 2005.


27. Dawkins J.C. et al. Acute Pyelonephritis in Pregnancy: A Retrospective Descriptive Hospital Based-Study. Pyelonephritis in Pregnancy: A Retrospective Descriptive Hospital Based-Study. ISRN Obstetrics and Gynecology. 2012;2012:519321.


28. Gilstrap L.C., Ramin S.M. Urinary tract infections during pregnancy. Obstetrics and Gynecology Clinics of North America. 2001;28(3):581–591.


29. Millar L.K., DeBuque L., Wing D.A. Uterine contraction frequency during treatment of pyelonephritis in pregnancy and subsequent risk of preterm birth. Journal of Perinatal Medicine. 2003;31(1):41–46.


30. Graham J.M., Oshiro B.T., Blanco J.D., Magee K.P. Uterine contractions after antibiotic therapy for pyelonephritis in pregnancy. American Journal of Obstetrics and Gynecology. 1993;168(2):577–580.


31. Cox S.M., Shelburne P., Mason R., Guss S., Cunningham F.G. Mechanisms of hemolysis and anemia associated with acute antepartum pyelonephritis. American Journal of Obstetrics and Gynecology. 1991;164(2):587–590.


32. van Nieuwkoop C., Hoppe BP, Bonten TN, Van’t Wout JW, Aarts NJ, Mertens BJ, Leyten EM, Koster T, Wattel-Louis GH, Delfos NM, Ablij HC, Elzevier HW, van Dissel JT. Predicting the need for radiologic imaging in adults with febrile urinary tract infection. Clin Infect Dis. 2010;51(11):1266–72. doi: 10.1086/657071.


33. Cattrall JWS, Robinson AV, Kirby A. A systematic review of randomised clinical trials for oral antibiotic treatment of acute pyelonephritis. Eur J Clin Microbiol Infect Dis. 2018;37(12):2285-2291. doi: 10.1007/s10096-018-3371-y.


34. Strohmeier Y, Hodson EM, Willis NS, Webster AC, Craig JC. Antibiotics for acute pyelonephritis in children. Cochrane Database of Systematic Reviews 2014, Issue 7. Art. No.: CD003772. DOI: 10.1002/14651858.CD003772.pub4


35. Pohl A. Modes of administration of antibiotics for symptomatic severe urinary tract infections. Cochrane Database of Systematic Reviews 2007, Issue 4. Art. No.: CD003237. DOI: 10.1002/14651858.CD003237.pub2.


36. Millar LK, Wing DA, Paul RH, Grimes DA. Outpatient treatment of pyelonephritis in pregnancy: a randomized controlled trial. Obstet Gynecol. 1995;86(4 Pt 1):560–64. doi: 10.1016/0029-7844(95)00244-l.


37. Wing DA, Hendershott CM, Debuque L, Millar LK. A randomized trial of three antibiotic regimens for the treatment of pyelonephritis in pregnancy. Obstet Gynecol. 1998;92(2):249–53. doi: 10.1016/s0029-7844(98)00156-2.


38. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, Moran GJ, Nicolle LE, Raz R, Schaeffer AJ, Soper DE; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-20. doi: 10.1093/cid/ciq257.


39. Hooton TM. Clinical practice. Uncomplicated urinary tract infection. N Engl J Med. 2012;366(11):1028-37. doi: 10.1056/NEJMcp1104429.


40. Arakawa S, Kawahara K, Kawahara M, Yasuda M, Fujimoto G, Sato A, Yokokawa R, Yoshinari T, Rhee EG, Aoyama N. The efficacy and safety of tazobactam/ceftolozane in Japanese patients with uncomplicated pyelonephritis and complicated urinary tract infection. J Infect Chemother. 2019;25(2):104-110. doi: 10.1016/j.jiac.2018.10.009.


41. Armstrong ES, Mikulca JA, Cloutier DJ, Bliss CA, Steenbergen JN. Outcomes of high-dose levofloxacin therapy remain bound to the levofloxacin minimum inhibitory concentration in complicated urinary tract infections. BMC Infect Dis. 2016;16(1):710. doi: 10.1186/s12879-016-2057-2.


42. Carmeli Y, Armstrong J, Laud PJ, Newell P, Stone G, Wardman A, Gasink LB. Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. Lancet Infect Dis. 2016;16(6):661-673. doi: 10.1016/S1473-3099(16)30004-4.


43. Weintraub A.S. et al. Antenatal antibiotic exposure in preterm infants with necrotising enterocolitis. J. Perinatol. 2012;32(9):705–709.


44. Ghidini A. et al. Does co-amoxiclav in preterm prom increase the risk of necrotising enterocolitis (NEC)? a meta-analysis. Am. J. Obstet. Gynecol. 2003;189(6):S170.


45. Lokshin K.L. Drainage of the upper urinary tract in acute pyelonephritis in pregnant women: Why? To whom? How long? Bulletin of Urology. 2019;7(3):35-40. https://doi.org/10.21886/2308-6424-2019-7-3-35-40. Russian (Локшин К.Л. Дренирование верхних мочевых путей при остром пиелонефрите у беременных: Зачем? Кому? Как долго? Вестник урологии. 2019;7(3):35-40. https://doi.org/10.21886/2308-6424-2019-7-3-35-40).


Об авторах / Для корреспонденции


А в т о р д л я с в я з и: К.Л. Локшин – д.м.н., руководитель центра оперативной урологии, онкоурологии и андрологии ООО «Джи Эм Эс Хоспитал», Москва, Россия; e-mail: k_lokshin@hotmail.com


Похожие статьи


Бионика Медиа